DY
Publicaties op Oncologisch.com
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA resul...
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III...
Neratinib plus fulvestrant plus trastuzumab bij HR+/HER2-mutant mammacarcinoom
PSA-daling met apalutamide plus ADT bij prostaatcarcinoom: TITAN analyse
Adjuvant axitinib versus placebo na nefrectomie bij niercelcarcinoom: ATLAS fase III